ZA885571B - Stable oxapenem-3-carboxylic acids - Google Patents

Stable oxapenem-3-carboxylic acids

Info

Publication number
ZA885571B
ZA885571B ZA885571A ZA885571A ZA885571B ZA 885571 B ZA885571 B ZA 885571B ZA 885571 A ZA885571 A ZA 885571A ZA 885571 A ZA885571 A ZA 885571A ZA 885571 B ZA885571 B ZA 885571B
Authority
ZA
South Africa
Prior art keywords
carbon
pharmaceutically acceptable
bonded
single bonds
groups
Prior art date
Application number
ZA885571A
Other languages
English (en)
Inventor
Hans Rolf Pfaeendler
Rolf Pfaeendler Hans
Wolfram Hendel
Hendel Wolfram
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA885571B publication Critical patent/ZA885571B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA885571A 1987-07-31 1988-07-29 Stable oxapenem-3-carboxylic acids ZA885571B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873725375 DE3725375A1 (de) 1987-07-31 1987-07-31 Stabile oxapenem-3-carbonsaeuren

Publications (1)

Publication Number Publication Date
ZA885571B true ZA885571B (en) 1989-04-26

Family

ID=6332772

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885571A ZA885571B (en) 1987-07-31 1988-07-29 Stable oxapenem-3-carboxylic acids

Country Status (20)

Country Link
US (1) US5096899A (zh)
EP (1) EP0301394B1 (zh)
JP (1) JPH0819135B2 (zh)
KR (1) KR890002169A (zh)
CN (1) CN1031533A (zh)
AT (1) ATE95521T1 (zh)
AU (1) AU618013B2 (zh)
CA (1) CA1339450C (zh)
DD (1) DD282012A5 (zh)
DE (2) DE3725375A1 (zh)
DK (1) DK425888A (zh)
ES (1) ES2060628T3 (zh)
FI (1) FI883553A (zh)
HU (1) HU203355B (zh)
IE (1) IE63026B1 (zh)
IL (1) IL87254A (zh)
NO (1) NO883188L (zh)
PH (1) PH27226A (zh)
PT (1) PT88118B (zh)
ZA (1) ZA885571B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3833693A1 (de) * 1988-10-04 1990-04-05 Bayer Ag Stabile oxapenem-3-carbonsaeuren und ihre verwendung als ss-lactamasehemmer
DE4027928A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Neue 2-tert.substituierte methyl-oxapenem-3-carbonsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung
DE4142423A1 (de) * 1991-12-20 1993-06-24 Pfaendler Hans Rudolf ((ls)-hydroxyalkyl)oxapenem-3-carbonsaeuren und ihre verwendung als betalactamasehemmer
EP1199077A1 (en) * 2000-10-19 2002-04-24 Amura Limited Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers
EP1326607B1 (en) * 2000-10-19 2008-07-23 Amura Limited Pharmaceutical compositions containing oxapenem-3-carboxilic acids
GB2369358A (en) * 2000-10-19 2002-05-29 Amura Ltd Oxapenems and pharmaceutical compositions thereof
GB0106428D0 (en) * 2001-03-15 2001-05-02 Amura Ltd Antibacterial composition
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
ES2428167T3 (es) 2007-05-21 2013-11-06 Hans Rudolf Pfaendler Composición farmacéutica bactericida activa anti-MRSA conteniendo carbapenemos
WO2009089380A2 (en) * 2008-01-08 2009-07-16 The Trustees Of Columbia University In The City Of New York Methods for p2ry5 mediated regulation of hair growth and mutants thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1368236A (en) * 1970-11-03 1974-09-25 Glaxo Lab Ltd Azetidinone derivatives and their preparation
AU498131B2 (en) * 1974-02-26 1979-02-15 Ciba-Geigy Ag Production of cephems by cyclization
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
CA1136132A (en) * 1975-02-17 1982-11-23 Teruji Tsuji Cyclization to form cephem ring and intermediates therefor
US4147864A (en) * 1975-02-20 1979-04-03 Ciba-Geigy Corporation Process for the manufacture of 7β-amino-3-cephem-3-ol-4 carboxylic acid compounds
US4024152A (en) * 1975-09-19 1977-05-17 Eli Lilly And Company 4-Dithio-3-imido-azetidin-2-ones
GB1529913A (en) * 1976-02-04 1978-10-25 Beecham Group Ltd Beta-lactam compounds
GB1591438A (en) * 1976-09-09 1981-06-24 Glaxo Lab Ltd Clavem derivatives
DE2740527A1 (de) * 1976-09-09 1978-03-16 Glaxo Lab Ltd Clavulansaeureabkoemmlinge und deren herstellung
GB1593275A (en) * 1976-10-22 1981-07-15 Glaxo Lab Ltd Clavam derivatives
DK139377A (da) * 1977-03-10 1978-09-11 Beecham Group Ltd Fremgangsmaade til fremstilling af ethere
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives

Also Published As

Publication number Publication date
DE3884705D1 (de) 1993-11-11
DK425888A (da) 1989-02-01
EP0301394B1 (de) 1993-10-06
KR890002169A (ko) 1989-04-08
DE3725375A1 (de) 1989-02-09
JPS6442484A (en) 1989-02-14
CA1339450C (en) 1997-09-09
EP0301394A1 (de) 1989-02-01
FI883553A0 (fi) 1988-07-28
PH27226A (en) 1993-05-04
ES2060628T3 (es) 1994-12-01
HUT48889A (en) 1989-07-28
DD282012A5 (de) 1990-08-29
HU203355B (en) 1991-07-29
IL87254A0 (en) 1988-12-30
AU2004088A (en) 1989-02-02
NO883188D0 (no) 1988-07-18
PT88118A (pt) 1989-06-30
FI883553A (fi) 1989-02-01
US5096899A (en) 1992-03-17
AU618013B2 (en) 1991-12-12
IL87254A (en) 1993-01-31
JPH0819135B2 (ja) 1996-02-28
DK425888D0 (da) 1988-07-29
PT88118B (pt) 1995-03-01
CN1031533A (zh) 1989-03-08
IE63026B1 (en) 1995-03-22
NO883188L (no) 1989-02-01
IE882347L (en) 1989-01-31
ATE95521T1 (de) 1993-10-15

Similar Documents

Publication Publication Date Title
AU643489B2 (en) Antibacterial agents - II
NO174806C (zh)
ZA918570B (en) Azasteroid compounds for the treatment of prostatic hypertrophy,their preparation and use
EP0327847A3 (en) Organopolysiloxane compositions curable into elastomers with elimination of alcohols
MY131501A (en) Process for the prepration of clavulanic acid
FI102069B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi
PH27226A (en) Stable oxapenem-3-carboxylic acids
FI904850A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 24-homo-D-vitamiinijohdannaisten valmistamiseksi
FR2649110B1 (fr) Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ZA886930B (en) Process for the synthesis of alpha n alkylated amino acids and esters thereof and to their application to the synthesis of carboxyalkyl dipeptides
AU2235688A (en) Process for the synthesis of alpha n alkylated amino acids and esters thereof. application to the synthesis of carboxyalkyl dipeptides.
HUT45058A (en) Process for producing 6-hydroxy-methyl-carbapenem derivatives and pharmaceuticals comprising the same as active ingredient
PT83204A (en) Process for preparing pharmaceutical compositions consisting of acylated phospholipios
ES2087421T3 (es) Acidos (1's)-hidroxialquiloxapenem-3-carboxilicos y su uso como inhibidor de la betalactamasa.
GB2282810A (en) Process for the preparation of clavulanic acid
HUT60495A (en) Process for producing ergoline derivatives and pharmaceutical compositions comprising such compounds
FR2608606B1 (fr) Derives d'acide dibenzo(be)oxepinne-acetique, leur preparation et leur application en therapeutique